2021
DOI: 10.1053/j.jvca.2020.09.101
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Automated Delivery of Propofol Using a Closed-Loop Anesthesia Delivery System in Patients Undergoing Thoracic Surgery: A Randomized Controlled Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 19 publications
0
4
0
Order By: Relevance
“… 21 Similar outcomes were found in thoracic patients. 22 One possible explanation for the difference was that the closed-loop TCI system regulated the infusion speed more frequently. This closed-loop system allowed monitoring of the BIS value in real time; the system allowed adjustment of the infusion rate every 15 seconds, which was more frequent than the systems used in other studies.…”
Section: Discussionmentioning
confidence: 99%
“… 21 Similar outcomes were found in thoracic patients. 22 One possible explanation for the difference was that the closed-loop TCI system regulated the infusion speed more frequently. This closed-loop system allowed monitoring of the BIS value in real time; the system allowed adjustment of the infusion rate every 15 seconds, which was more frequent than the systems used in other studies.…”
Section: Discussionmentioning
confidence: 99%
“…Propofol (Pro), an intravenous anesthetic, is generally used for the sedation of surgical patients [14,15]. Remarkably, Pro administration has shown to attenuate organ I/R injury and improve surgical outcomes in clinical and preclinical settings [11,[16][17][18].…”
Section: Agingmentioning
confidence: 99%
“…13 However, evidence for propofol TIVA as alternative technique is expanding for its positive clinical effects (decreased incidence of postoperative nausea-and-vomiting, anti-inflammatory effect, antineoplastic action), lower greenhouse impact, and versatility in administering using precision systems (target-controlled infusion, closed-loop automation). 5,14,15 Although low-certainty evidence suggests that propofol TIVA improves QoR-40 on day of surgery in patients undergoing noncardiac surgery; there is limited work to account for full-scope postanesthesia recovery outcomes after major robotic surgery under GA. 16 This randomized study explored the hypothesis that use of automated propofol TIVA would benefit postoperative patient recovery while maintaining a robust GA state intraoperatively and assessed postoperative recovery using a QoR-15 questionnaire in patients undergoing elective robotic surgery under automated propofol-TIVA (administered by closedloop anesthesia delivery system [CLADS]) [17][18][19][20] or desflurane inhalation GA in terms of overall QoR-15 score postoperative day 1 (POD-1) and postoperative day 2 (POD-2) (primary outcome variables), individual QoR-15 item scores (15 nos. ), intraoperative hemodynamics (heart rate, mean blood pressure), anesthesia depth consistency, anesthesia delivery system performance, early recovery from anesthesia (time-to-eye-opening, and time to tracheal extubation), and postoperative adverse events (sedation, PONV, pain, intraoperative awareness recall) (secondary outcome variables).…”
mentioning
confidence: 99%
“…This randomized study explored the hypothesis that use of automated propofol TIVA would benefit postoperative patient recovery while maintaining a robust GA state intraoperatively and assessed postoperative recovery using a QoR-15 questionnaire in patients undergoing elective robotic surgery under automated propofol-TIVA (administered by closed-loop anesthesia delivery system [CLADS]) 17–20 or desflurane inhalation GA in terms of overall QoR-15 score postoperative day 1 (POD-1) and postoperative day 2 (POD-2) (primary outcome variables), individual QoR-15 item scores (15 nos. ), intraoperative hemodynamics (heart rate, mean blood pressure), anesthesia depth consistency, anesthesia delivery system performance, early recovery from anesthesia (time-to-eye-opening, and time to tracheal extubation), and postoperative adverse events (sedation, PONV, pain, intraoperative awareness recall) (secondary outcome variables).…”
mentioning
confidence: 99%